Hostname: page-component-5447f9dfdb-vwtfw Total loading time: 0 Render date: 2025-07-28T05:19:19.916Z Has data issue: false hasContentIssue false
  • English
  • Français

Ivabradine treatment of atrial arrhythmia in an adolescent following heart transplantation

Published online by Cambridge University Press:  27 June 2025

Stefan Kurath-Koller Open the ORCID record for Stefan Kurath-Koller [Opens in a new window] ,
Lisa Sallmon  and
Hannes Sallmon Open the ORCID record for Hannes Sallmon [Opens in a new window]
Stefan Kurath-Koller
Affiliation:
Division of Pediatric Cardiology, Medical University of Graz, Graz, Austria
Lisa Sallmon
Affiliation:
Division of Pediatric Cardiology, Medical University of Graz, Graz, Austria
Hannes Sallmon*
Affiliation:
Division of Pediatric Cardiology, Medical University of Graz, Graz, Austria
*
Corresponding author: Hannes Sallmon; Email: hannes.sallmon@medunigraz.at
Get access Rights & Permissions [Opens in a new window]

Abstract

Premature atrial complexes are frequent among patients after heart transplantation. We herein report on the successful use of ivabradine in a 15-year old patient who exhibited marked palpitations caused by atrial premature complexes after orthotopic bicaval heart transplantation.

Keywords

atrial arrhythmiaantiarrhythmic treatmentcardiac transplantation

Information

Type
Case Report
Information
Cardiology in the Young , Volume 35 , Issue 6 , June 2025 , pp. 1290 - 1291
Check for updates
Copyright
© The Author(s), 2025. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Bonnet, D, Berger, F, Jokinen, E, Kantor, PF, Daubeney, PEF. Ivabradine in children with dilated cardiomyopathy and symptomatic chronic heart failure. J Am Coll Cardiol. 2017; 70: 1262–1272.CrossRefGoogle ScholarPubMed
Janson, CM, Tan, RB, Iyer, VR, Vogel, RL, Vetter, VL, Shah, MJ. Ivabradine for treatment of tachyarrhythmias in children and young adults. HeartRhythm Case Rep. 2019; 5: 333–337.CrossRefGoogle ScholarPubMed
Oeffl, N, Schober, L, Faudon, P, et al. Antiarrhythmic drug dosing in children-review of the literature. Children (Basel). 2023; 10: 847.Google ScholarPubMed
Rivinius, R, Helmschrott, M, Rahm, AK, et al. Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation. Clin Res Cardiol. 2022; 111: 141–153.CrossRefGoogle ScholarPubMed
Ogawa, Y, Urata, S, Inuzuka, R. Successful use of ivabradine in a 10-year-old patient with graft failure after heart transplantation. Cardiol Young. 2023; 33: 649–651.CrossRefGoogle Scholar
Dieks, JK, Klehs, S, Müller, MJ, Paul, T, Krause, U. Adjunctive ivabradine in combination with amiodarone: a novel therapy for pediatric congenital junctional ectopic tachycardia. Heart Rhythm. 2016; 13: 1297–1302.CrossRefGoogle ScholarPubMed
Krishna, MR, Kunde, MF, Kumar, RK, Balaji, S. Ivabradine in post-operative junctional ectopic tachycardia (JET): breaking new ground. Pediatr Cardiol. 2019; 40: 1284–1288.CrossRefGoogle ScholarPubMed
Younis, NK, Abi-Saleh, B, Al Amin, F, et al. Ivabradine: a potential therapeutic for children with refractory SVT. Front Cardiovasc Med. 2021; 8: 660855.CrossRefGoogle ScholarPubMed
Gómez-Ganda, L, Parramón-Teixidó, CJ, Giralt-García, G, Fernández-García, C, Ferrer-Menduiña, Q, Cabañas-Poy, MJ. Ivabradine in treatment of symptomatic heart failure and supraventricular tachycardias in patients under six months of age. Front Pharmacol. 2025; 16: 1502375.CrossRefGoogle ScholarPubMed
Ergul, Y, Ozturk, E, Ozgur, S, Ozyurt, A, Cilsal, E, Guzeltas, A. Ivabradine is an effective antiarrhythmic therapy for congenital junctional ectopic tachycardia-induced cardiomyopathy during infancy: case studies. Pacing Clin Electrophysiol. 2018; 41: 1372–1377.CrossRefGoogle Scholar